Mode
Text Size
Log in / Sign up
N/A N=52 Treatment

Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using Shapematch Cutting Guides:Sub-Study A

Arthroplasties, Replacement, Knee

Enrolled (actual)
52
Serious AEs
3.9%
Results posted
Jan 2016
Primary outcome: Primary: Repeatability of Cutting Guide Position — 0.990; 0.963; 0.936; 0.910 intraclass correlation coefficient (ICC)

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Shapematch Cutting Guides (Device)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
Stryker South Pacific
Primary completion
Sep 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Repeatability of Cutting Guide Position
0.990; 0.963; 0.936; 0.910; 0.993; 0.994

Summary

This is a prospective, non-randomized, study of the clinical outcomes of participants that receive the Stryker Triathlon® Total Knee System for Total Knee Arthroplasty implanted using ShapeMatch® Cutting Guides.

Eligibility Criteria

Inclusion Criteria

  • The patient is a male or non-pregnant female between the ages of 50-90.
  • The patient requires a primary total knee replacement and is indicated for computer-assisted surgery.
  • The patient has a primary diagnosis of osteoarthritis (OA).
  • The patient has intact collateral ligaments.
  • The patient is able to undergo MRI scanning of the affected limb.
  • The patient has signed the study specific, HREC-approved, Informed Consent document.
  • The patient is willing and able to comply with the specified pre-operative and post-operative clinical and radiographic evaluations.

Exclusion Criteria

  • The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
  • The patient has had a high tibial osteotomy or femoral osteotomy.
  • The patient is morbidly obese (BMI ≥ 40).
  • The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
  • The patient has a varus/valgus malalignment ≥ 15° (relative to mechanical axis).
  • The patient has a fixed flexion deformity ≥ 15°.
  • The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
  • The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • The patient has a cognitive impairment, an intellectual disability or a mental illness.
  • The patient is pregnant.
  • The patient has metal hardware present in the region of the hip, knee or ankle (as this is known to create geometrical distortion in the region of the implant).
  • The patient has any known contraindications for undergoing assessment by MRI (e.g. ferrous implants, metallic clips, magnetically activated implanted devices such as cardiac pacemakers, etc).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02516163). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search